BABINE: An original and user-friendly scale for the simple and quick management of herb-drug interactions in clinical practice
2024

BABINE: A New Scale for Managing Herb-Drug Interactions

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): Cnudde Anthony, Allely Camille, Biset Natacha, Champy Pierre, Fouilhé Nathalie, Huret Fanny, Lawson Sibi, Mercan Aline, Noukela Noumi Doris Pascale, Michalet Serge, Montis Andrea, Pochet Stephanie, Schils Audrey, Tangeten Cecilia, Tod Michel, Van Antwerpen Pierre, Vervacke Audrey, Souard Florence

Primary Institution: Université libre de Bruxelles (ULB), Brussels, Belgium

Hypothesis

The study proposes a new scoring method to evaluate the risk of herb-drug interactions based on expert consensus.

Conclusion

The BABINE scale simplifies the assessment of herb-drug interaction risks and provides a transparent evaluation method.

Supporting Evidence

  • The scale was developed through expert consensus using the Delphi method.
  • Iterative rounds of evaluation helped refine the scoring criteria.
  • The scale aims to improve the management of herb-drug interactions in clinical practice.
  • Existing scales for herb-drug interactions were found to be inadequate.
  • The study emphasizes the importance of clear and interpretable guidelines for healthcare professionals.
  • Experts from various fields contributed to the development of the scale.
  • The scale focuses on real-life data from clinical studies and case reports.
  • The final tool is designed to be user-friendly for healthcare practitioners.

Takeaway

This study created a new tool to help doctors quickly understand if mixing herbs with medications is safe or risky.

Methodology

The study developed the BABINE scale through iterative rounds of expert discussions and evaluations of clinical case reports and studies.

Potential Biases

Potential biases may arise from the subjective interpretation of case reports and expert opinions.

Limitations

The scale focuses only on textual information and does not account for mechanistic interpretations of interactions.

Participant Demographics

Experts from pharmacology, pharmacognosy, and medicine were involved in the scale development.

Digital Object Identifier (DOI)

10.1186/s12906-024-04706-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication